EUVIMEDEUVIMED entdecken
Crossref

Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samples

Hsiao-Wen Kao, Hung Chang, Ming-Chung Kuo, Jin-Hou Wu, Ying-Jung Huang, Ting-Yu Huang, Tung-Huei Lin iD, Lee-Yung Shih iD

Cancer · 2025

DOI: 10.1002/cncr.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Hsiao-Wen Kao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Clonal Evolution, Blast Crisis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Science and Technology Council, Ministry of Health and Welfare, Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic analysis of paired samples from patients with myeloproliferative neoplasm in chronic and blastic phases (BP) revealed the common presence of clonal hematopoiesis‐related mutations other than driver mutations, stable driver CALR mutations, frequent loss of JAK2‐ V617F, and acquisition of mutations in RUNX1 , TP53 , ASXL1 , or signaling pathways during BP progression. Losses of JAK2‐ V617F were associated with a shorter time to BP, highlighting distinct genetic evolution patterns and their clinical implications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloproliferative DisordersClonal EvolutionBlast CrisisHumansFemaleMaleMiddle AgedMutationAgedAdultJanus Kinase 2Aged, 80 and overDisease ProgressionHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

blastic phase progressionclonal evolutionmyeloproliferative neoplasmsnext generation sequencingpaired sample analysis

Substanzen

Janus Kinase 2JAK2 protein, human

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
  • School of Medicine, Chang Gung University, Taoyuan, Taiwan.
  • Division of Hematology-Oncology, Department of Internal Medicine, New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan.

ORCID-Profile: Tung-Huei Lin, Lee-Yung Shih

Förderung

  • National Science and Technology Council
  • Ministry of Health and Welfare
  • Chang Gung Memorial Hospital

Zitieren

APA

Kao, H. W., Chang, H., Kuo, M. C., Wu, J. H., Huang, Y. J., Huang, T. Y., Lin, T. H., & Shih, L. Y. (2025). Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samples. Cancer. https://doi.org/10.1002/cncr.70048

Vancouver

Kao HW, Chang H, Kuo MC, Wu JH, Huang YJ, Huang TY, et al. Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samples. Cancer. 2025. doi:10.1002/cncr.70048

BibTeX
@article{Kao2025,
  author = {Kao, Hsiao-Wen and Chang, Hung and Kuo, Ming-Chung and Wu, Jin-Hou and Huang, Ying-Jung and Huang, Ting-Yu and Lin, Tung-Huei and Shih, Lee-Yung},
  title = {Genetic evolution of myeloproliferative neoplasms from chronic phase to blastic phase: An analysis of 46 paired samples},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70048}
}
Kostenlos starten →